Vimarsana
Biggest News Aggregation in the World

Page 22 - Research Square News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Square. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Square Today - Breaking & Trending Today

Study suggests COVID-19 can cause diabetes - Vimarsana News

Study suggests COVID-19 can cause diabetes

The authors of a new study under review at Nature Portfolio and currently posted to the Research Square preprint* server showed the clinical possibility that the coronavirus disease 2019 (COVID-19) heightens the risk of developing diabetes mellitus (DM), supporting diabetes screening in those infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The dissemination and consumption of medical literature is evolving - Vimarsana News

The dissemination and consumption of medical literature is evolving

- PMLiVE

Source: pmlive.com
Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines? - Vimarsana News

Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?

A new study aimed to analyze whether the order of immunization of vaccine types impacted the efficacy of a heterologous prime-boost vaccination strategy.

Low Bone Hormone Tied to Worse Cardiac Risk in Type 2 Diabetes - Vimarsana News

Low Bone Hormone Tied to Worse Cardiac Risk in Type 2 Diabetes

Age- and sex-related differences in the relationship between levels of a bone-derived hormone, osteocalcin, and cardiometabolic risk factors are apparent in study of patients with type 2 diabetes.

Radioiodine's Benefit Absent in Low-Risk Thyroid Cancer - Vimarsana News

Radioiodine's Benefit Absent in Low-Risk Thyroid Cancer

Routine radioiodine ablation had no incremental benefit in patients with low-risk, differentiated thyroid cancer after total thyroidectomy, results from a prospective, nonrandomized study suggest.